Related Experiment Video
Updated: Mar 24, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
Giuseppe Cianciolo1, Irene Capelli1, Maria Cappuccilli1
1Nephrology, Dialysis and Renal Transplant Unit, S. Orsola Hospital, Department of Experimental Diagnostic and Specialty Medicine (DIMES) , University of Bologna , Bologna , Italy.
Insights
Circulating calcifying cells (CCCs) contribute to vascular calcification, a complication linked to chronic kidney disease-mineral and bone disorders (CKD-MBD). Research is exploring CCC origins and the role of CKD-MBD in their formation and vascular disease progression.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Endocrinology
Background:
- Vascular calcification is a significant risk factor for cardiovascular morbidity and mortality, particularly in patients with chronic kidney disease-mineral and bone disorders (CKD-MBD).
- Vascular calcification involves an osteogenic cellular program, with circulating calcifying cells (CCCs), derived from bone marrow (BM), implicated in intima calcification.
- The role of CCCs in conditions like diabetes and atherosclerosis, and their precise origin (BM, bloodstream, or both), remain largely unexplored.
Purpose of the Study:
- To investigate the role of circulating calcifying cells (CCCs) in vascular calcification, especially in the context of chronic kidney disease-mineral and bone disorders (CKD-MBD).
- To explore the potential link between CKD-MBD and the formation and function of CCCs.
- To understand the factors influencing CCC formation and their contribution to the bone-vascular axis.
Main Methods:
- Analysis of existing studies on circulating calcifying cells (CCCs) and their association with vascular calcification.
- Review of preliminary data concerning CKD patients and the impact of mineral bone disease on vascular calcification.
- Exploration of the potential role of parathyroid hormone and osteoblasts in regulating hematopoietic stem/progenitor cells and CCC formation.
Main Results:
- Studies in non-CKD patients have not found associations between CCCs and bone metabolism markers.
- Preliminary findings in CKD patients suggest that disruptions in bone marrow (BM) niches due to CKD-MBD may contribute to vascular calcification.
- CKD-MBD is hypothesized to promote CCC formation due to its effects on hematopoietic stem/progenitor cells.
Conclusions:
- Circulating calcifying cells (CCCs) are implicated in vascular calcification, a process linked to CKD-MBD.
- CKD-MBD may promote vascular calcification by disrupting bone marrow (BM) integrity and potentially increasing CCC formation.
- Further research is needed to elucidate the exact mechanisms of CCC formation and their role in the bone-vascular axis, particularly in the context of CKD, diabetes, and atherosclerosis.
Abstract:
Vascular calcification, occurring during late-stage vascular and valvular disease, is highly associated with chronic kidney disease-mineral and bone disorders (CKD-MBD), representing a major risk factor for cardiovascular morbidity and mortality. The hallmark of vascular calcification, which involves both media and intima, is represented by the activation of cells committed to an osteogenic programme. Several studies have analysed the role of circulating calcifying cells (CCCs) in vascular calcification. CCCs are bone marrow (BM)-derived cells with an osteogenic phenotype, participating in intima calcification processes and defined by osteocalcin and bone alkaline phosphatase expression. The identification of CCCs in diabetes and atherosclerosis is the most recent, intriguing and yet uncharted chapter in the scenario of the bone-vascular axis. Whether osteogenic shift occurs in the BM, the bloodstream or both, is not known, and also the factors promoting CCC formation have not been identified. However, it is possible to recognize a common pathogenic commitment of inflammation in atherosclerosis and diabetes, in which metabolic control may also have a role. Currently available studies in patients without CKD did not find an association of CCCs with markers of bone metabolism. Preliminary data on CKD patients indicate an implication of mineral bone disease in vascular calcification, as a consequence of functional and anatomic integrity interruption of BM niches. Given the pivotal role that parathyroid hormone and osteoblasts play in regulating expansion, mobilization and homing of haematopoietic stem/progenitors cells, CKD-MBD could promote CCC formation.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Skeleton and Calcium Homeostasis

